Douglas Wood

955 total citations
29 papers, 644 citations indexed

About

Douglas Wood is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Douglas Wood has authored 29 papers receiving a total of 644 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Pulmonary and Respiratory Medicine and 7 papers in Molecular Biology. Recurrent topics in Douglas Wood's work include Lung Cancer Treatments and Mutations (7 papers), Economic and Financial Impacts of Cancer (4 papers) and Cancer Genomics and Diagnostics (4 papers). Douglas Wood is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Economic and Financial Impacts of Cancer (4 papers) and Cancer Genomics and Diagnostics (4 papers). Douglas Wood collaborates with scholars based in United States, Canada and China. Douglas Wood's co-authors include Michel Girodo, Solomon Henry, Shufeng Li, Julia Chang, Anne Lynn S. Chang, Shalini Mohan, Holbrook E. Kohrt, Robert V. Rouse, Irene Wapnir and Nora Hansen and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and Blood.

In The Last Decade

Douglas Wood

27 papers receiving 617 citations

Peers

Douglas Wood
Sujata M. Patil United States
Michael Fara United States
John M. Sorensen United States
Lois Browne Australia
Yi Pang United States
Melissa P. Mitchell United States
Samu Kurki Finland
Sujata M. Patil United States
Douglas Wood
Citations per year, relative to Douglas Wood Douglas Wood (= 1×) peers Sujata M. Patil

Countries citing papers authored by Douglas Wood

Since Specialization
Citations

This map shows the geographic impact of Douglas Wood's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Douglas Wood with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Douglas Wood more than expected).

Fields of papers citing papers by Douglas Wood

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Douglas Wood. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Douglas Wood. The network helps show where Douglas Wood may publish in the future.

Co-authorship network of co-authors of Douglas Wood

This figure shows the co-authorship network connecting the top 25 collaborators of Douglas Wood. A scholar is included among the top collaborators of Douglas Wood based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Douglas Wood. Douglas Wood is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Wu, Julie, Eunji Choi, Nathaniel J. Myall, et al.. (2023). Overall Survival Among Patients With De Novo Stage IV Metastatic and Distant Metastatic Recurrent Non–Small Cell Lung Cancer. JAMA Network Open. 6(9). e2335813–e2335813. 6 indexed citations
3.
Narasimhan, Balasubramanian, et al.. (2023). Use of EMR data to validate performance of machine learning prognostic models for patients with cancer.. JCO Oncology Practice. 19(11_suppl). 512–512. 1 indexed citations
5.
Wu, Julie, Victoria Y. Ding, Sophia J. Luo, et al.. (2022). Predictive Model to Guide Brain Magnetic Resonance Imaging Surveillance in Patients With Metastatic Lung Cancer: Impact on Real-World Outcomes. JCO Precision Oncology. 6(6). e2200220–e2200220. 4 indexed citations
6.
Gensheimer, Michael F., et al.. (2022). Accuracy of Electronic Medical Record Follow-Up Data for Estimating the Survival Time of Patients With Cancer. JCO Clinical Cancer Informatics. 6(6). e2200019–e2200019. 4 indexed citations
7.
Wharton, Keith A., et al.. (2021). Tissue Multiplex Analyte Detection in Anatomic Pathology – Pathways to Clinical Implementation. Frontiers in Molecular Biosciences. 8. 672531–672531. 20 indexed citations
8.
Gensheimer, Michael F., Sonya Aggarwal, Justin N. Carter, et al.. (2020). Automated model versus treating physician for predicting survival time of patients with metastatic cancer. Journal of the American Medical Informatics Association. 28(6). 1108–1116. 27 indexed citations
9.
Wu, Julie, Daniel H. Kwon, Michael Glover, et al.. (2020). Changes in Cancer Management due to COVID-19 Illness in Patients with Cancer in Northern California. JCO Oncology Practice. 17(3). e377–e385. 12 indexed citations
10.
Chernikova, Sophia B., Stephano S. Mello, Jason H. Stafford, et al.. (2018). Dynamin impacts homology-directed repair and breast cancer response to chemotherapy. Journal of Clinical Investigation. 128(12). 5307–5321. 15 indexed citations
11.
Myall, Nathaniel J., Solomon Henry, Douglas Wood, et al.. (2018). Natural Disease History, Outcomes, and Co-mutations in a Series of Patients With BRAF-Mutated Non–small-cell Lung Cancer. Clinical Lung Cancer. 20(2). e208–e217. 9 indexed citations
12.
Wood, Douglas, Trevor Hastie, Sonya Aggarwal, et al.. (2018). Automated survival prediction in metastatic cancer patients using high-dimensional electronic medical record data. Annals of Oncology. 29. viii548–viii548. 5 indexed citations
13.
Gensheimer, Michael F., Douglas Wood, Trevor Hastie, et al.. (2018). Automated Survival Prediction in Metastatic Cancer Patients Using High-Dimensional Electronic Medical Record Data. JNCI Journal of the National Cancer Institute. 111(6). 568–574. 42 indexed citations
14.
Mohan, Shalini, et al.. (2016). Increased Risk of Cutaneous Squamous Cell Carcinoma After Vismodegib Therapy for Basal Cell Carcinoma. JAMA Dermatology. 152(5). 527–527. 85 indexed citations
15.
Marlenga, Barbara, Richard L. Berg, James G. Linneman, et al.. (2012). Determinants of early-stage hearing loss among a cohort of young workers with 16-year follow-up. Occupational and Environmental Medicine. 69(7). 479–484. 30 indexed citations
16.
Berg, Richard L., William Pickett, Steven K. Broste, et al.. (2009). Hearing conservation program for agricultural students: Short-term outcomes from a cluster-randomized trial with planned long-term follow-up. Preventive Medicine. 49(6). 546–552. 19 indexed citations
17.
Kohrt, Holbrook E., Richard A. Olshen, Honnie R. Bermas, et al.. (2008). New models and online calculator for predicting non-sentinel lymph node status in sentinel lymph node positive breast cancer patients. BMC Cancer. 8(1). 66–66. 196 indexed citations
18.
Kwon, Soon Yong, Tong Lin, Hiroshi Takei, et al.. (2001). Alterations in the adhesion behavior of osteoblasts by titanium particle loading: Inhibition of cell function and gene expression. Biorheology. 38(2-3). 161–183. 23 indexed citations
19.
Kwon, Soon Yong, Hiroshi Takei, Dominique P. Pioletti, et al.. (2000). Titanium particles inhibit osteoblast adhesion to fibronectin‐coated substrates. Journal of Orthopaedic Research®. 18(2). 203–211. 24 indexed citations
20.
Kwon, Soon Yong, Hiroshi Takei, Dominique P. Pioletti, et al.. (2000). Titanium Particles Inhibit Osteoblast Adhesion to Fibronectin-coated Substrates. Journal of Bone and Joint Surgery. 82(6). 30–30. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026